Clinical Trials · NCT00771017

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Name: Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Withdrawn
Sponsor: Eastern Cooperative Oncology Group
Enrollment: 0
Start date: Jul 2008
Locations: See registry
Primary endpoint: Median PSA recurrence-free survival in patients in patients responding to the study treatments

View Gonadorelin compound reference